Corporate Roundtable (CRT)

The AACI Corporate Roundtable provides a forum for AACI cancer centers to address topics of mutual interest with their pharmaceutical industry colleagues. This interaction has the potential to advance the progress of research and ultimately benefit patients with cancer and their families.

AACI HHS Clinical Trial Diversity Policy Recommendations 08182022
AACI_HHS_Clinical_Trial_Diversity_Policy_Recommendations_08182022.pdf - [127.3 KB pdf]